Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats

Phytomedicine

Volumn 17, Issue 8-9, 2010, Pages 674-678

  Murphy, K ^a   Kubin, Z J ^b   Shepherd, J N ^b   Ettinger, R H ^a  

^a EASTERN OREGON UNIVERSITY   (United States)

^b GONZAGA UNIVERSITY   (United States)

Author keywords

anxiolytic; benzodiazepine; elevated plus maze; GABA; valerenic acid; Valeriana officinalis

Indexed keywords

4 AMINOBUTYRIC ACID; ALCOHOL; DIAZEPAM; VALERIAN; VALERIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL RAT; FEMALE; MAZE TEST; NONHUMAN; PHYTOCHEMISTRY; PLANT ROOT; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; DIAZEPAM; ETHANOL; FEMALE; GAMMA-AMINOBUTYRIC ACID; INDENES; MAZE LEARNING; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; RATS; SESQUITERPENES; VALERIAN;

RATTUS; RATTUS NORVEGICUS; VALERIANA; VALERIANA OFFICINALIS;

EID: 77952292512     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.10.020     Document Type: Article

References (15)

1. Al-Awadi M., Pavlik A., and Al-Sarraf H. Increased brain uptake and brain to blood efflux transport of 14C-GABA in spontaneously hypertensive rats. Life Sci. 79 9 (2006) 847-853
2. Awad R., Levac D., Cybulska P., Merali Z., Trudeau V.L., and Arnason J.T. Effects of traditionally used anxiolytic botanicals of enzymes of the γ-aminobutyric acid (GABA) system. Can. J. Phys. Pharmacol. 85 9 (2007) 933-942
3. A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology 56 1 (2009) 174-181
4. 5a receptor in vitro. Brain Res. Mol. Brain Res. 138 2 (2005) 191-197
5. Donath F., Quispe S., Diefenbach K., Maurer A., Fietze I., and Roots I. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 33 2 (2000) 47-53
6. Hattesohl M., Feistel B., Sievers H., Lehnfeld R., Hegger M., and Winterhoff H. Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties. Phytomedicine 15 1-2 (2008) 2-15
7. Hendriks H., Bos R., Woerdenbag H.J., and Koster S. Central nervous depressant activity of valerenic acid in the mouse. Planta Med. 1 (1985) 28-31
8. A receptors: molecular mechanism and subunit specificity. Neuropharmacology 53 1 (2007) 178-187
9. Metzeler K., Agoston A., and Gratzl M. An intrinsic gamma-aminobutyric acid (GABA)ergic system in the adrenal cortex: findings from human and rat adrenal glands and the NCI-H295R cell line. Endocrinology 145 5 (2004) 2402-2411
10. Müller C., Schumacher B., Brattström A., Abourashed E.A., and Koetter U. Interaction of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors. Life Sci. 71 16 (2002) 1939-1949
11. Pellow S., Chopin P., File S., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14 3 (1985) 149-167
12. Phillis J.W., and O'Regan M.H. The role of adenosine in the central actions of the benzodiazepines. Prog. Neuro-Psychopharmacol. Bio. Psychiatry 12 4 (1988) 384-404
13. Somers J.M., Goldner E.M., Waraich P., and Hsu L. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can. J. Psychiatry 51 2 (2006) 100-112
14. Stewart S.H., and Westra H.A. Benzodiazepine side-effects: from the bench to the clinic. Cur. Pharmaceut. Des. 8 1 (2002) 1-3
15. Wingrove P.B., Wafford K.A., Bain C., and Witting P.J. The modulatory action of loreclezole at the γ-aminobutyric acid type A receptor is determined by a single amino acid in the β2 and β3 subunit. Proc. Natl. Acad. Sci. 91 (1994) 4569-4573